Statement re Award Win
November 12 2021 - 8:00AM
Statement re Award Win
DXS INTERNATIONAL PLC
Award AQSE Company of
the Year
(“DXSP”)
DXS International ("DXSP" or "the Company"), the
AQSE Growth Market quoted healthcare information and digital
clinical decision support systems provider, is delighted to
announce that at the ninth Annual Small Cap Awards held yesterday
evening at London’s Montcalm Hotel the Company won the award for
“AQSE Company of the Year”.
The Small Cap Awards shine a light on the best
companies and participants in the small and micro-cap community
(sub £200m market capitalisation) across nine categories. They are
a once-in-a-year opportunity to recognise outstanding achievement
focused on smaller quoted companies.
Commenting on DXS's Awards success, David
Immelman, CEO of DXS said:
"These awards are deserved recognition for the
Company's outstanding performance over the past year which has seen
the business maintain and grow its revenue and profits. I am
delighted to see the hard work of all our staff in challenging
circumstances recognised by the judging panel. The Covid-19
pandemic has added new impetus to the realization that health care
delivery is urgently in need of a major overhaul and DXS, with deep
knowledge and experience in the electronic health care space, is
well-positioned to exploit this fast-emerging opportunity. ”
The Directors of DXS International plc accept
responsibility for this announcement.
Contacts:
David
Immelman (Chief
Executive)DXS International plc |
01252 719800david@dxs-systems.com |
https://www.dxs-systems.co.uk |
|
Corporate
Advisor |
|
City &
Merchant David Papworth |
020 7101 7676 |
Corporate
Broker |
|
Hybridan LLPClaire Louise
Noyce |
020 3764 2341 |
Notes to Editors
About DXS:
DXS International presents up to date treatment
guidelines and recommendations, from Clinical Commissioning Groups
and other trusted NHS sources, to doctors, nurses and pharmacists
in their workflow and during the patient consultation. This
effective clinical decision support ultimately translates to
improved healthcare outcomes delivered more cost effectively and
which should significantly contribute towards the NHS achieving its
projected efficiency savings.
DXS (AQSE:DXSP)
Historical Stock Chart
From Jun 2024 to Jul 2024
DXS (AQSE:DXSP)
Historical Stock Chart
From Jul 2023 to Jul 2024